Cytokinetics (CYTK) AGM 2026 summary

Opening remarks and agenda

• The meeting was called to order with introductions of the board, executive committee, and independent auditor present.

Board and executive committee updates

• Three directors, Ed Kaye, Wendell Wierenga, and Nancy Wysenski, were nominated and subsequently reelected as Class I directors to serve until the 2029 annual meeting.

Shareholder proposals

• Five proposals were presented: election of directors, amendment to the Employee Stock Purchase Plan, ratification of auditors, advisory vote on executive compensation, and other formal business.